The Future of Infectious Diseases and Molecular Diagnostics connecting cutting-edge scientific innovation with real-world clinical and public health applications.
Officially Supported By
The FutureDX Summit is a premier international conference focused on infectious diseases and molecular diagnostics. It is designed to connect cutting-edge scientific innovation with real-world clinical and public health applications.
As global health challenges such as emerging pathogens, antimicrobial resistance, and growing immunocompromised populations continue to intensify, rapid, accurate, and scalable molecular diagnostics have become essential.
Conceptualised and curated by Convolign Business Consulting, this high-impact summit in London brings together diagnostic professionals, clinicians, laboratory leaders, technologists, biotech innovators, and public health stakeholders from across the globe.
About the SummitMultiplex PCR, genomic sequencing, and lateral flow technologies pushing the boundaries of infectious disease detection.
How artificial intelligence forecasts outbreaks and guides personalised treatment strategies for infectious disease management.
The role of diagnostics in early antimicrobial resistance detection, stewardship programmes, and resistance surveillance.
Innovations in rapid, field-deployable testing for emergency care, remote locations, and low-resource settings worldwide.
How changing climate conditions influence disease transmission patterns and drive the evolution of diagnostics.
Infectious disease, pathology, microbiology & genomics professionals
CEOs, R&D Scientists & Diagnostic Developers
Professors and PIs leading molecular research
Government agencies, UKHSA, ECDC & global health strategists
Gain direct access to AI-enabled platforms and next-gen clinical workflows transforming diagnostics globally.
Network with 120+ key stakeholders through structured sessions and networking events.
Hear from internationally recognised leaders in precision medicine and molecular diagnostics.
Validated case studies and models ready for implementation.
Agenda designed by industry experts — not vendor driven.
Placeholder percentages — update with confirmed figures before launch.
The infectious disease diagnostics landscape represents one of the fastest-growing sectors in UK and global life sciences — and why FutureDX Summit sits at its centre.
Growing at ~3.7% CAGR (2025–2030), driven by PCR, genomic testing & advanced diagnostics
Percentage of NHS trusts using PCR and genomic sequencing in workflows
Active molecular diagnostics and infectious disease companies
Increase in UK hospital admissions linked to antimicrobial-resistant infections
Healthcare systems integrating AI/ML tools for disease detection
Increase in diagnostics use in emergency and community care settings
FutureDX Summit 2026 is bringing together 25+ world-class speakers from infectious disease science, molecular diagnostics, and global public health.
Antimicrobial Stewardship Lead Training Programme Director West Midlands (Infectious diseases/ Microbiology Training)
University Hospital of Coventry and Warwickshire
Director of the Unit of Clinical Microbiology. Director of the Unit of Clinical Virology
University Hospital of Parma
Consultant Microbiologist & Director for Infection Prevention & Control (DIPC) Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust
Nethermayne Basildon
Principal Investigator And Project Lead for Medical Research Council And Wellcome Trust IAA Project
University of Cambridge
Microbiome and AMR Research Lead
University of LeedsRegistration & Morning Coffee
Keynote: The Future of Infectious Disease Diagnostics
Sepsis Diagnostics — Speed & Clinical Impact
Networking Coffee Break
Drug-Resistant TB — Diagnostic Challenge
BBV Screening in Community Settings
Networking Lunch
Rapid Diagnostic Services — Sponsor Session
Evening Drinks Reception
AI in Diagnostics
Precision Medicine
Panel Discussion
Closing Keynote
Two intensive days spanning the full diagnostics spectrum — from clinical science to AI, regulatory strategy, and global health.
End of Day 1
Both Days
Both Days
FutureDX Summit 2026 is bringing together 25+ world-class speakers from infectious disease science, molecular diagnostics, and global public health.
Sponsoring FutureDX 2026 places your brand at the centre of the molecular diagnostic transformation. Unlike generic events, your technology is showcased in a curated, solution-focused discourse.
A dedicated branded speaking slot to present your solution directly to senior decision-makers as part of the main programme. Available to Headline, Platinum and Gold sponsors.
Your own stand for live demos, product showcases and direct delegate engagement throughout both conference days.
Receive the full delegate list with names, titles and organisations for structured post-event follow-up with every attendee.
Pre-arranged, confirmed meetings with your most relevant prospects. Up to 15 per sponsor depending on tier. No chasing, no cold outreach.
Your logo on the website, agenda, event app, brochure, delegate badges and all on-site materials before, during and after the event.
FutureDX runs alongside Bio-Shield Conference 2026 at the same venue. Your sponsorship puts your brand in front of both audiences at once.
BioShield Conference 2026 is a premier gathering dedicated to biosecurity, infectious disease preparedness, and the science of protecting populations from biological threats. Running alongside FutureDX Summit, BioShield brings together global health security experts, public health officials, and life sciences innovators to address the most pressing biosecurity challenges of our time — making the combined event one of the most comprehensive infectious disease gatherings in the UK.
Three pass types from £649. Register early for the inaugural edition.
View Registration & PassesDirect access to 120+ infectious disease diagnostics decision-makers.
View Sponsorship PackagesFull venue details will be shared with registered delegates. Central London venue — accessible by tube, rail, and air.
Our team responds within 24 business hours. Reach us directly.
